Showing results (11-20 of 69) with videos related to

Sort By:
Pageof 7
Journal of Gastroenterology and Hepatology|February 3, 2023
Methods of tissue preparation after EUS-guided tissue acquisition without rapid on-site assessment: Results of a randomized studyVinh-An Phan, Andrew Ruszkiewicz, Romina Safaeian, et al.
Pathology|July 12, 2014
Immunohistochemistry with the anti-BRAF V600E (VE1) antibody: impact of pre-analytical conditions and concordance with DNA sequencing in colorectal and papillary thyroid carcinomaKaterina Dvorak, Birte Aggeler, John Palting, et al.
World Journal of Gastroenterology|June 18, 2005
Detection of lymph nodes micrometastases in Dukes' A and B colorectal cancer using anti-cytokeratin antibodies AE1/AE3Zhi-Wei Zhou, Nick Rieger, Andrew Ruszkiewicz, et al.
Molecular Cancer|January 13, 2006
BRAF mutations are associated with distinctive clinical, pathological and molecular features of colorectal cancer independently of microsatellite instability statusWei Qi Li, Kazuyuki Kawakami, Andrew Ruszkiewicz, et al.
World Journal of Gastroenterology|October 27, 2010
Real-time histology with the endocytoscopeRajvinder Singh, Swee Lin Chen Yi Mei, William Tam, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|March 2, 2016
Annexin A2 and S100A10 are independent predictors of serous ovarian cancer outcomeNoor A Lokman, Carmen E Pyragius, Andrew Ruszkiewicz, et al.
Forensic Science, Medicine, and Pathology|August 14, 2020
Signet-ring cell appearance of atrophic fat cellsJohn D Gilbert, Neil E I Langlois, Andrew Ruszkiewicz, et al.
ANZ Journal of Surgery|June 14, 2006
Use of ethylenediaminetetraacetic acid for in vivo stripping of columnar mucosa: pilot study in an experimental modelMichael France, Paul A Drew, Andrew Ruszkiewicz, et al.
ANZ Journal of Surgery|November 15, 2013
Conventional adverse features do not predict response to adjuvant chemotherapy in stage II colon cancerSze-Lin Peng, Michelle Thomas, Andrew Ruszkiewicz, et al.
International Journal of Molecular Sciences|February 23, 2011
MALDI Imaging Mass Spectrometry (MALDI-IMS)-application of spatial proteomics for ovarian cancer classification and diagnosisJohan O R Gustafsson, Martin K Oehler, Andrew Ruszkiewicz, et al.
Pageof 7